About Incando Therapeutics

Founded in 2019, Incando Therapeutics is a medical technology firm developing light-based therapies for intractable, hard to treat cancers. Incando is currently targeting brain cancer (Glioblastoma) with a view towards applying our solutions to other variants of the disease. Recognising the established MedTech ecosystem in Singapore and how the nation has, in recent years, become a hotbed for the MedTech sector, the firm seeks to develop novel and safer solutions for cancer therapy, complementing current methods that are already in use.